Mangoceuticals (MGRX) Current Leases (2022 - 2026)

Mangoceuticals has disclosed Current Leases across 5 years of filings, most recently posting $57058.0 for Q1 2026.

• Current Leases for Q1 2026 came in at $57058.0, up 19.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $57058.0 (up 19.59% YoY), and the FY2025 annual result was $307823.0, up 373.85% from the prior year.
• Current Leases came in at $57058.0 for Q1 2026 at Mangoceuticals, down from $307823.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $307823.0 in Q4 2025 to a low of $12167.0 in Q3 2025.
• The 5-year median for Current Leases is $61034.5 (2023), against an average of $73078.3.
• Peak annual rise in Current Leases reached 373.85% in 2025, while the deepest fall reached 82.45% in 2025.
• Mangoceuticals' Current Leases stood at $56725.0 in 2022, then grew by 12.33% to $63718.0 in 2023, then climbed by 1.95% to $64962.0 in 2024, then soared by 373.85% to $307823.0 in 2025, then slumped by 81.46% to $57058.0 in 2026.
• The last three Current Leases figures came in at $57058.0 (Q1 2026), $307823.0 (Q4 2025), and $12167.0 (Q3 2025), per Business Quant data.